Syndax Pharmaceuticals (SNDX)
(Delayed Data from NSDQ)
$23.28 USD
-0.11 (-0.47%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $23.28 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth B Momentum F VGM
Earnings News For SNDX
-
Syndax: Q1 Earnings Snapshot
-
Syndax Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Clinical and Business Update
-
Syndax: Q4 Earnings Snapshot
-
Syndax: Q4 Earnings Snapshot
-
Syndax Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Clinical and Business Update
-
Syndax: Q3 Earnings Snapshot
-
Syndax Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Clinical and Business Update
-
Syndax Pharmaceuticals Reports Second Quarter 2023 Financial Results and Provides Clinical and Business Update
-
Syndax: Q1 Earnings Snapshot
-
Syndax Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Business Update
-
Syndax: Q4 Earnings Snapshot
-
Syndax: Q4 Earnings Snapshot
-
Syndax Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Clinical and Business Update
-
Syndax (SNDX) to Report Q4 Earnings: What's in the Cards?
-
Syndax: Q3 Earnings Snapshot
-
Syndax Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Clinical and Business Update
-
Syndax: Q2 Earnings Snapshot
-
Syndax Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Clinical and Business Update
-
Syndax Pharmaceuticals (SNDX) Reports Q1 Loss, Lags Revenue Estimates
-
Syndax Pharmaceuticals (SNDX) Reports Q2 Loss, Misses Revenue Estimates
-
Earnings Preview: Syndax Pharmaceuticals (SNDX) Q2 Earnings Expected to Decline
-
Syndax Pharmaceuticals (SNDX) Reports Q1 Loss, Misses Revenue Estimates
-
Syndax Pharmaceuticals (SNDX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
-
Syndax Pharmaceuticals (SNDX) Reports Q4 Loss
-
Syndax Pharmaceuticals (SNDX) Reports Q3 Loss, Misses Revenue Estimates